|
Volumn 3, Issue SUPPL. 3, 1998, Pages 45-55
|
Molecular tools for the treatment of hepatitis C
a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALPHA INTERFERON;
ANTIVIRUS AGENT;
ENZYME INHIBITOR;
RIBAVIRIN;
VIRUS ENZYME;
VIRUS RNA;
CLINICAL TRIAL;
CONFERENCE PAPER;
COST EFFECTIVENESS ANALYSIS;
DRUG POTENTIATION;
GENETIC ANALYSIS;
GENETIC HETEROGENEITY;
HEPATITIS C;
HUMAN;
LIVER CELL CARCINOMA;
LIVER CIRRHOSIS;
NONHUMAN;
PRIORITY JOURNAL;
QUANTITATIVE DIAGNOSIS;
REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;
VIREMIA;
VIRUS GENOME;
VIRUS LOAD;
VIRUS REPLICATION;
VIRUS RESISTANCE;
ANTIVIRAL AGENTS;
BIOLOGICAL MARKERS;
DRUG RESISTANCE, MICROBIAL;
GENETIC TECHNIQUES;
GENOTYPE;
HEPACIVIRUS;
HEPATITIS C, CHRONIC;
HUMANS;
INTERFERON-ALPHA;
RIBAVIRIN;
RNA, VIRAL;
TIME FACTORS;
VARIATION (GENETICS);
VIRAL LOAD;
VIREMIA;
VIRUS REPLICATION;
|
EID: 0031763162
PISSN: 13596535
EISSN: None
Source Type: Journal
DOI: None Document Type: Conference Paper |
Times cited : (4)
|
References (77)
|